Skip to content
Want to stay in the know?
Sign up for email updates
.
What We Do
Programs
Impact
Europe
Events
Media
Tools & Platforms
Give
Presentations
Towards EMA Qualification of Islet Auto-Antibodies as a Model-Based Clinical Trial Enrichment Platform for Type-1 Diabetes Prevention Studies
October 21, 2019
print
pdf
share
×